Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein.

PubWeight™: 1.71‹?› | Rank: Top 3%

🔗 View Article (PMC 38063)

Published in Proc Natl Acad Sci U S A on October 15, 1996

Authors

T Mebatsion1, K K Conzelmann

Author Affiliations

1: Department of Clinical Virology, Federal Research Centre for Virus Diseases of Animals, Tübingen, Germany.

Articles citing this

Virus maturation by budding. Microbiol Mol Biol Rev (1998) 3.78

Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27

Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol (1999) 2.70

Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J (1998) 2.64

Negative-strand RNA viruses: genetic engineering and applications. Proc Natl Acad Sci U S A (1996) 2.47

Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. J Virol (2011) 1.99

The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. J Virol (2000) 1.96

Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J Virol (1998) 1.95

The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol (2010) 1.86

Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons. Nat Protoc (2010) 1.77

Chimeric measles viruses with a foreign envelope. J Virol (1998) 1.75

Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J Virol (1997) 1.72

Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Natl Acad Sci U S A (1997) 1.53

Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine. J Virol (2000) 1.52

Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein. J Virol (2000) 1.34

Design and generation of recombinant rabies virus vectors. Nat Protoc (2013) 1.27

Double-labeled rabies virus: live tracking of enveloped virus transport. J Virol (2007) 1.22

A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc Natl Acad Sci U S A (2000) 1.13

Characterization of a single-cycle rabies virus-based vaccine vector. J Virol (2010) 1.07

Heterologous exchanges of the glycoprotein and the matrix protein in a Novirhabdovirus. J Virol (2002) 1.02

Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells. J Virol (2002) 1.01

The NV gene of snakehead rhabdovirus (SHRV) is not required for pathogenesis, and a heterologous glycoprotein can be incorporated into the SHRV envelope. J Virol (2004) 0.95

Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes. J Virol (2003) 0.91

Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses. J Infect Dis (2015) 0.86

Rhabdovirus-based vaccine platforms against henipaviruses. J Virol (2014) 0.84

Applications and challenges of multivalent recombinant vaccines. Hum Vaccin Immunother (2012) 0.84

Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J Virol (1998) 0.83

Vesicular stomatitis virus-simian retrovirus type 2 vaccine protects macaques from detectable infection and B-cell destruction. J Virol (2011) 0.79

ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo. PLoS One (2014) 0.79

Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4. Retrovirology (2005) 0.77

Articles cited by this

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26

Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell (1989) 9.68

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A (1993) 9.17

Infectious rabies viruses from cloned cDNA. EMBO J (1994) 8.35

Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc Natl Acad Sci U S A (1988) 6.33

A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci U S A (1994) 4.86

Assembly and morphology of HIV: potential effect of structure on viral function. AIDS (1991) 4.73

Budding of rabies virus particles in the absence of the spike glycoprotein. Cell (1996) 4.46

Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins. J Virol (1994) 4.10

The budding mechanisms of enveloped animal viruses. J Gen Virol (1980) 4.08

The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J Virol (1996) 3.89

Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol (1989) 3.81

The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50

Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol (1986) 2.65

Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J Virol (1993) 2.54

Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res Hum Retroviruses (1991) 2.52

Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc Natl Acad Sci U S A (1988) 2.47

Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell (1994) 2.08

Genetic manipulation of non-segmented negative-strand RNA viruses. J Gen Virol (1996) 1.95

The budding mechanism of spikeless vesicular stomatitis virus particles. EMBO J (1986) 1.81

A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J Virol (1992) 1.80

Highly stable expression of a foreign gene from rabies virus vectors. Proc Natl Acad Sci U S A (1996) 1.72

Rabies virus glycoprotein is a trimer. Virology (1992) 1.57

Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles. J Virol (1992) 1.28

Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. J Virol (1995) 1.19

Articles by these authors

Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol (1999) 8.66

Infectious rabies viruses from cloned cDNA. EMBO J (1994) 8.35

Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol (1999) 2.70

Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J Virol (2000) 2.62

A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell (1997) 2.35

Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study. J Gen Virol (2000) 2.29

Highly stable expression of a foreign gene from rabies virus vectors. Proc Natl Acad Sci U S A (1996) 1.72

Polymerase activity of in vitro mutated rabies virus L protein. Virology (1995) 1.44

Virus promoters determine interference by defective RNAs: selective amplification of mini-RNA vectors and rescue from cDNA by a 3' copy-back ambisense rabies virus. J Virol (1999) 1.40

Mapping the interacting domains between the rabies virus polymerase and phosphoprotein. J Virol (1998) 1.34

Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region. J Gen Virol (2007) 1.32

Differential transcription attenuation of rabies virus genes by intergenic regions: generation of recombinant viruses overexpressing the polymerase gene. J Virol (2000) 1.22

Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. J Virol (1995) 1.19

Ambisense gene expression from recombinant rabies virus: random packaging of positive- and negative-strand ribonucleoprotein complexes into rabies virions. J Virol (1997) 1.15

Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4. Vet Microbiol (1999) 1.06

Molecular characterization of positive-strand RNA viruses: pestiviruses and the porcine reproductive and respiratory syndrome virus (PRRSV). Arch Virol Suppl (1993) 0.93

Recombinant rhabdoviruses: vectors for vaccine development and gene therapy. Curr Top Microbiol Immunol (2005) 0.88

Molecular analysis of rabies-related viruses from Ethiopia. Onderstepoort J Vet Res (1993) 0.80

Infection characteristics of rabies virus variants with deletion or insertion in the pseudogene sequence. J Neurovirol (1998) 0.79

Regulatory structures of gene expression, DNA-replication and DNA-rearrangement in macronuclear genes of Stylonychia lemnae, a hypotrichous ciliate. Eur J Protistol (2012) 0.76

[Neuronal expression of foreign genes with recombinant rabies virus variants]. Rev Neurol (Paris) (2000) 0.76